jo.\*:("Leukemia")
Results 1 to 25 of 10103
Selection :
5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotypeCASTRO, F. V; MCGINN, O. J; GALLEGO, A et al.Leukemia. 2012, Vol 26, Num 7, pp 1487-1498, issn 0887-6924, 12 p.Article
A role for Danazol in chronic lymphocytic leukemiaTUNG, S; SPANER, D. E.Leukemia. 2012, Vol 26, Num 7, pp 1684-1686, issn 0887-6924, 3 p.Article
AML1/ETO and POU4F1 synergy drives B-lymphoid gene expression typical of t(8;21) acute myeloid leukemiaDUNNE, J; MANNARI, D; FARZANEH, T et al.Leukemia. 2012, Vol 26, Num 5, pp 1131-1135, issn 0887-6924, 5 p.Article
Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinibGEORGIOU, G; EFTHYMIOU, A; BARTZI, V et al.Leukemia. 2012, Vol 26, Num 4, pp 824-826, issn 0887-6924, 3 p.Article
Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AMLETTOU, S; AUDUREAU, E; SOLARY, E et al.Leukemia. 2012, Vol 26, Num 10, pp 2297-2299, issn 0887-6924, 3 p.Article
Functional role of BAALC in leukemogenesisHEUSER, M; BERG, T; KUCHENBAUER, F et al.Leukemia. 2012, Vol 26, Num 3, pp 532-536, issn 0887-6924, 5 p.Article
Glycolysis inhibition targets Mcl-1 to restore sensitivity of lymphoma cells to ABT-737-induced apoptosisMEYNET, O; BENETEAU, M; JACQUIN, M. A et al.Leukemia. 2012, Vol 26, Num 5, pp 1145-1147, issn 0887-6924, 3 p.Article
Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVONDAENEN, S; DER HOLT, B. Van; BREEMS, D. A et al.Leukemia. 2012, Vol 26, Num 7, pp 1726-1729, issn 0887-6924, 4 p.Article
Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro modelHOLLINK, Ihim; FENG, Q; PIETERS, R et al.Leukemia. 2012, Vol 26, Num 2, pp 371-373, issn 0887-6924, 3 p.Article
NIH-defined graft-versus-host disease after reduced intensity or myeloablative conditioning in patients with acute myeloid leukemiaTERWEY, T. H; VEGA-RUIZ, A; HEMMATI, P. G et al.Leukemia. 2012, Vol 26, Num 3, pp 536-542, issn 0887-6924, 7 p.Article
Obesity and the risk of chronic myelogenous leukemia: is this another example of the neoplastic effects of increased body fat?LICHTMAN, M. A.Leukemia. 2012, Vol 26, Num 1, pp 183-184, issn 0887-6924, 2 p.Article
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implicationsDAMM, F; THOL, F; GUERCI-BRESLER, A et al.Leukemia. 2012, Vol 26, Num 5, pp 1137-1140, issn 0887-6924, 4 p.Article
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patientsLASHO, T. L; FINKE, C. M; HANSON, C. A et al.Leukemia. 2012, Vol 26, Num 5, pp 1135-1137, issn 0887-6924, 3 p.Article
Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomideGÖHRING, G; LANGE, K; SCHLEGELBERGER, B et al.Leukemia. 2012, Vol 26, Num 2, pp 356-358, issn 0887-6924, 3 p.Article
The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemiaWHITMAN, S. P; CALIGIURI, M. A; MENDLER, J. H et al.Leukemia. 2012, Vol 26, Num 7, pp 1713-1717, issn 0887-6924, 5 p.Article
Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemiaELTER, T; JAMES, R; STAIB, P et al.Leukemia. 2012, Vol 26, Num 12, pp 2549-2552, issn 0887-6924, 4 p.Article
Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathwayXU, S; EVANS, H; CAMP, B. V et al.Leukemia. 2012, Vol 26, Num 12, pp 2546-2549, issn 0887-6924, 4 p.Article
A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myelomaBERENSON, J. R; YELLIN, O; VESCIO, R et al.Leukemia. 2012, Vol 26, Num 7, pp 1675-1680, issn 0887-6924, 6 p.Article
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1CHAIB, H; NEBBIOSO, A; PREBET, T et al.Leukemia. 2012, Vol 26, Num 4, pp 662-674, issn 0887-6924, 13 p.Article
Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cellsAME-THOMAS, P; LE PRIOL, J; FEST, T et al.Leukemia. 2012, Vol 26, Num 5, pp 1053-1063, issn 0887-6924, 11 p.Article
Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environmentMALDEGEM, F. Van; WORMHOUDT, Tam; NOESEL, Cjm Van et al.Leukemia. 2012, Vol 26, Num 7, pp 1647-1653, issn 0887-6924, 7 p.Article
Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemiaENCISO-MORA, V; HOSKING, F. J; GREAVES, M et al.Leukemia. 2012, Vol 26, Num 10, pp 2212-2215, issn 0887-6924, 4 p.Article
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program StudyVISCO, C; LI, Y; D'AMORE, Esg et al.LI, Y; Leukemia. 2012, Vol 26, Num 9, pp 2103-2113, issn 0887-6924, 11 p.Article
Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphomaANSELL, S. M; TANG, H; SILBERSTEIN, P. T et al.Leukemia. 2012, Vol 26, Num 5, pp 1046-1052, issn 0887-6924, 7 p.Article
Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemiaBILLARD, C.Leukemia. 2012, Vol 26, Num 9, pp 2032-2038, issn 0887-6924, 7 p.Article